Mager, Donald E.

General Pharmacokinetic Model for Drugs Exhibiting Target-Mediated Drug Disposition

Mager, D. E., & Jusko, W. J. (2001) · Journal of Pharmacokinetics and Pharmacodynamics

Pharmacogenetics and Drug MetabolismStatistical Methods in Clinical Trials

Cited by 605

Testosterone concentrations in diabetic and nondiabetic obese men

Dhindsa, S., Miller, M. G., McWhirter, C. L., Mager, D. E., Ghanim, H., Chaudhuri, A., & Dandona, P. (2010) · Diabetes Care

Hormonal and reproductive studiesHypothalamic control of reproductive hormones

Cited by 352

Simultaneous population pharmacokinetic modelling of ketamine and three major metabolites in patients with treatment-resistant bipolar depression

Zhao, X., Venkata, S. L. V., Moaddel, R., Luckenbaugh, D. A., Brutsche, N. E., Ibrahim, L., Zarate Jr, C. A., Mager, D. E., & Wainer, I. W. (2012) · British Journal of Clinical Pharmacology

Treatment of Major DepressionPharmacogenetics and Drug Metabolism

Cited by 137

The impact of tacrolimus exposure on extrarenal adverse effects in adult renal transplant recipients

Campagne, O., Mager, D. E., Brazeau, D., Venuto, R. C., & Tornatore, K. M. (2019) · British Journal of Clinical Pharmacology

Renal Transplantation Outcomes and TreatmentsStatistical Methods in Clinical Trials

Cited by 31

Integrated QSPR–pharmacodynamic model of genomic effects of several corticosteroids

Mager, D. E., Pyszczynski, N. A., & Jusko, W. J. (2003) · Journal of Pharmaceutical Sciences

Computational Drug Discovery MethodsAdrenal Hormones and Disorders

Cited by 19